Approval · Notice of Compliance 5296 · 1995
VERAPAMIL: Notice of Compliance 5296
Issued May 6, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5296
- Date
- May 6, 1995
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antiarrhythmic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VERAPAMIL | 02166739 | Marketed |
Medicinal ingredients
- VERAPAMIL HCL 2.5 MG per ML